Ex-J&J Doc Defends Co.'s Opioid Marketing In Okla. Trial
A former medical director at Johnson & Johnson subsidiary Janssen Pharmaceuticals on Friday defended the company's marketing of opioids as having a low risk of addiction during cross-examination by an attorney...To view the full article, register now.
Already a subscriber? Click here to view full article